1型糖尿病心血管疾病的遗传风险因素:DCCT/EDIC研究
本研究在DCCT/EDIC研究的1371名1型糖尿病患者中,利用全基因组基因分型获得多基因风险评分(PRS)和个体遗传变异,采用Cox比例风险模型分析遗传因素与心血管疾病(CVD)风险的关联。结果发现,冠状动脉疾病PRS与任何CVD和主要不良心血管事件(MACE)风险显著相关,且独立于年龄、血脂、血压和血糖等传统风险因素。
要点
- CAD PRS每增加1个标准差,任何CVD风险未调整和完全调整后分别增加42%和38%(P<0.0001)。
- CAD PRS每增加1个标准差,MACE风险未调整和完全调整后分别增加50%和40%(P<0.0001)。
- 遗传因素对1型糖尿病患者CVD风险的预测价值独立于传统风险因素。
核心结论
- 遗传因素与1型糖尿病患者后续CVD风险相关,且独立于年龄、血脂、血压和血糖等既定风险因素。
研究设计与样本
- 研究基于DCCT/EDIC队列,对1371名参与者进行全基因组基因分型,获取PRS和个体遗传变异。
- 采用Cox比例风险模型评估遗传因素与CVD风险的关联,并调整年龄、血脂、血压和血糖等因素。
主要发现
- CAD PRS与任何CVD风险显著相关:未调整模型每1-SD风险增加42%,完全调整模型增加38%(P<0.0001)。
- CAD PRS与MACE风险显著相关:未调整模型每1-SD风险增加50%,完全调整模型增加40%(P<0.0001)。
- 多个个体单核苷酸多态性(SNP)与任何CVD和MACE风险名义相关。
关键数值与推荐
- CAD PRS每增加1个标准差,任何CVD风险未调整增加42%、完全调整增加38%(P<0.0001)。
- CAD PRS每增加1个标准差,MACE风险未调整增加50%、完全调整增加40%(P<0.0001)。
临床怎么用
- 在1型糖尿病患者中,可考虑结合CAD PRS评估CVD风险,以补充传统风险因素的不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The role of genetic factors in the risk of cardiovascular disease (CVD) for patients with type 1 diabetes (T1D) remains unknown. We therefore examined whether previously identified genetic factors for coronary artery disease (CAD) are associated with the risk of CVD above and beyond established demographic and clinical factors in the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) study. RESEARCH DESIGN AND METHODS: Polygenic risk scores (PRS) and individual genetic variants identified in previous studies were obtained from genome-wide genotyping performed in 1,371 DCCT/EDIC participants. Two composite CVD outcomes were considered: major adverse cardiovascular events (MACE) (CVD death or nonfatal myocardial infarction [MI] or stroke) and any CVD (MACE plus confirmed angina, silent MI, revascularization, or congestive heart failure). Cox proportional hazards models assessed the association between the genetic factors and the risk of CVD with adjustment for other factors (including age, lipids, blood pressure, and glycemia). RESULTS: CAD PRS was strongly associated with the subsequent risk of any CVD (42% and 38% higher risk per 1-SD increase in unadjusted and fully adjusted models, respectively; P < 0.0001) and with the risk of MACE (50% and 40% higher risk per 1-SD increase in unadjusted and fully adjusted models, respectively; P < 0.0001). Several individual single nucleotide polymorphisms were also nominally associated with the risk of any CVD and MACE. CONCLUSIONS: Genetic factors are associated with the risk of subsequent CVD in individuals with T1D above and beyond the effect of established risk factors such as age, lipids, blood pressure, and glycemia.
引用
- Bebu I, Keshavarzi S, Gao X, et al. Genetic Risk Factors for CVD in Type 1 Diabetes: The DCCT/EDIC Study. Diabetes Care. 2021. PMID: 33883194. doi:10.2337/dc20-2388
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。